In ERα + BC, nuclear expression of ERβ2 was associated with better clinical outcome, while cytoplasmic ERβ2 expression correlated with poor survival; nuclear ERβ5, but not ERβ1, significantly was related with better overall survival [49]. The gene discussed is ESR1; the disease is breast cancer.